Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort

Schizophrenia Research

Volumn 168, Issue 1-2, 2015, Pages 84-91

  Austin, Stephen F ^a,b   Mors, Ole ^a   Budtz Jørgensen, Esben ^b   Secher, Rikke Gry ^b   Hjorthøj, Carsten R ^b   Bertelsen, Mette ^b   Jeppesen, Pia ^b   Petersen, Lone ^b   Thorup, Anne ^b   Nordentoft, Merete ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Course of illness; Schizophrenia; Symptom trajectories

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SOCIAL INTERACTION; SUBSTANCE ABUSE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; STATISTICAL MODEL; YOUNG ADULT;

ADULT; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84942373214     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.07.021     Document Type: Article

References (75)

1. Alphs L. An industry perspective on the NIMH consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:225-230.
2. Alvarez-Jimenez M., Gleeson J.F., Henry L.P., Harrigan S.M., Harris M.G., Amminger G.P., Killackey E., Yung A.R., Herrman H., Jackson H.J., McGorry P.D. Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis. Schizophr. Res. 2011, 125:236-246.
3. Alvarez-Jimenez M., Gleeson J.F., Henry L.P., Harrigan S.M., Harris M.G., Killackey E., Bendall S., Amminger G.P., Yung A.R., Herrman H., Jackson H.J., McGorry P.D. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5years. Psychol. Med. 2012, 42:595-606.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorder 1994, (Washington, DC). 4th ed.
5. Andreasen N.C., Flaum M., Swayze V.W., Tyrrell G., Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch. Gen. Psychiatry 1990, 47:615-621.
6. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 2005, 162:441-449.
7. Anthony W. Recovery from mental illness: the guiding vision of the mental health service system in the 1990's. J. Psychosocial Rehabil. 1993, 11-23.
8. Arndt S., Andreasen N.C., Flaum M., Miller D., Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch. Gen. Psychiatry 1995, 52:352-360.
9. Austin S.F., Mors O., Secher R.G., Hjorthoj C.R., Albert N., Bertelsen M., Jensen H., Jeppesen P., Petersen L., Randers L., Thorup A., Nordentoft M. Predictors of recovery in first episode psychosis: the OPUS cohort at 10year follow-up. Schizophr. Res. 2013, 150:163-168.
10. Bartko J.J., Carpenter W.T. On the methods and theory of reliability. J. Nerv. Ment. Dis. 1976, 163:307-317.
11. Bertelsen M., Jeppesen P., Petersen L., Thorup A., Ohlenschlaeger J., le Q.P., Christensen T.O., Krarup G., Jorgensen P., Nordentoft M. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch. Gen. Psychiatry 2008, 65:762-771.
12. Beunckens C., Molenberghs G., Verbeke G., Mallinckrodt C. A latent-class mixture model for incomplete longitudinal Gaussian data. Biometrics 2008, 64:96-105.
13. Birchwood M., Todd P., Jackson C. Early intervention in psychosis. The critical period hypothesis. Br. J. Psychiatry Suppl. 1998, 172:53-59.
14. Boonstra N., Klaassen R., Sytema S., Marshall M., De H.L., Wunderink L., Wiersma D. Duration of untreated psychosis and negative symptoms - a systematic review and meta-analysis of individual patient data. Schizophr. Res. Dec 2012, 142:12-19.
15. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull. 2007, 33:1013-1022.
16. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8:470-484.
17. Case M., Stauffer V.L., Ascher-Svanum H., Conley R., Kapur S., Kane J.M., Kollack-Walker S., Jacob J., Kinon B.J. The heterogeneity of antipsychotic response in the treatment of schizophrenia. Psychol. Med. 2010, 1-10.
18. Cavelti M., Beck E.M., Kvrgic S., Kossowsky J., Vauth R. The role of subjective illness beliefs and attitude toward recovery within the relationship of insight and depressive symptoms among people with schizophrenia spectrum disorders. J. Clin. Psychol. 2012, 68:462-476.
19. Crumlish N., Whitty P., Clarke M., Browne S., Kamali M., Gervin M., McTigue O., Kinsella A., Waddington J.L., Larkin C., O'Callaghan E. Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br. J. Psychiatry 2009, 194:18-24.
20. Davidson L., McGlashan T.H. The varied outcomes of schizophrenia. Can. J. Psychiatry 1997, 42:34-43.
21. Elis O., Caponigro J.M., Kring A.M. Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions. Clin. Psychol. Rev. 2013, 33:914-928.
22. Erhart S.M., Marder S.R., Carpenter W.T. Treatment of schizophrenia negative symptoms: future prospects. Schizophr. Bull. 2006, 32:234-237.
23. Galderisi S., Mucci A., Bitter I., Libiger J., Bucci P., Wolfgang F.W., Kahn R.S., For The Eufest Study Group Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. Eur. Neuropsychopharmacol. Mar 2012, 23(3):196-204.
24. Ginsberg D.L., Schooler N.R., Buckley P.F., Harvey P.D., Weiden P.J. Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning. CNS Spectr. 2005, 10:1-13.
25. Goghari V.M., Harrow M., Grossman L.S., Rosen C. A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders. Psychol. Med. 2013, 43:1151-1160.
26. Hafner H., Riecher-Rossler A., Hambrecht M., Maurer K., Meissner S., Schmidtke A., Fatkenheuer B., Loffler W., van der Heiden W. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr. Res. 1992, 6:209-223.
27. Harris M.G., Henry L.P., Harrigan S.M., Purcell R., Schwartz O.S., Farrelly S.E., Prosser A.L., Jackson H.J., McGorry P.D. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr. Res. 2005, 79:85-93.
28. Harrow M., Sands J.R., Silverstein M.L., Goldberg J.F. Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schizophr. Bull. 1997, 23:287-303.
29. Harrow M., Grossman L.S., Jobe T.H., Herbener E.S. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr. Bull. 2005, 31:723-734.
30. Henry L.P., Amminger G.P., Harris M.G., Yuen H.P., Harrigan S.M., Prosser A.L., Schwartz O.S., Farrelly S.E., Herrman H., Jackson H.J., McGorry P.D. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7years after index admission. J. Clin. Psychiatry 2010, 71:716-728.
31. Henry L.P., Amminger G.P., Harris M.G., Yuen H.P., Harrigan S.M., Prosser A.L., Schwartz O.S., Farrelly S.E., Herrman H., Jackson H.J., McGorry P.D. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7years after index admission. J. Clin. Psychiatry 2010, 71:716-728.
32. Herbener E.S., Harrow M. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients. Schizophr. Bull. 2001, 27:527-537.
33. Herbener E.S., Harrow M. Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis. Schizophr. Bull. 2004, 30:813-825.
34. Jeppesen P., Petersen L., Thorup A., Abel M.B., Ohlenschlaeger J., Christensen T.O., Krarup G., Jorgensen P., Nordentoft M. The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychol. Med. 2008, 38:1157-1166.
35. Klingberg S., Wolwer W., Engel C., Wittorf A., Herrlich J., Meisner C., Buchkremer G., Wiedemann G. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr. Bull. 2011, 37(Suppl. 2):S98-S110.
36. Lambert M., Karow A., Leucht S., Schimmelmann B.G., Naber D. Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5years later. Dialogues Clin. Neurosci. 2010, 12:393-407.
37. Levine S.Z., Leucht S. Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories. Biol. Psychiatry 2010, 68:86-92.
38. Levine S.Z., Lurie I., Kohn R., Levav I. Trajectories of the course of schizophrenia: from progressive deterioration to amelioration over three decades. Schizophr. Res. 2011, 126:184-191.
39. Little R., Rubin D. Statistical Analysis With Missing Data 1987, Wiley, New York.
40. Melle I., Larsen T.K., Haahr U., Friis S., Johannesen J.O., Opjordsmoen S., Rund B.R., Simonsen E., Vaglum P., McGlashan T. Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. Arch. Gen. Psychiatry 2008, 65:634-640.
41. Menezes N.M., Arenovich T., Zipursky R.B. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol. Med. 2006, 36:1349-1362.
42. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 2005, 162:495-506.
43. Morrison A.P., Shryane N., Beck R., Heffernan S., Law H., McCusker M., Bentall R.P. Psychosocial and neuropsychiatric predictors of subjective recovery from psychosis. Psychiatry Res. 2013, 208:203-209.
44. Mulder R.T., Joyce P.R., Frampton C. Relationships among measures of treatment outcome in depressed patients. J. Affect. Disord. 2003, 76:127-135.
45. Muthen B., Brown H. Estimating drug effects in the presence of placebo response: causal inference using growth mixture modelling. Stat. Med. 2009, 28:3363-3385.
46. Muthen L., Muthen B. Mplus: Statistical Analysis with Latent Variables, Version 7 edn. Los Angeles 2012.
47. Muthen B., Brown C., Masyn K., Jo B., Khoo S., Yang C. 2002, Biostatistics Oxford, England.
48. Neil S., Kilbride M., Pitt L., Nothard S., Welford M., Sellwood W., Morrison A. The Questionnaire About the Process of Recovery (QPR): a measurement tool developed in collaboration with service users. Psychosis 2009, 1:145-155.
49. Norman R.M., Townsend L., Malla A.K. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br. J. Psychiatry 2001, 179:340-345.
50. Pedersen G., Hagtvet K.A., Karterud S. Generalizability studies of the Global Assessment of Functioning - Split version. Compr. Psychiatry 2007, 48:88-94.
51. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 2005, 162:1785-1804.
52. Petersen L., Jeppesen P., Thorup A., Abel M.B., Ohlenschlaeger J., Christensen T.O., Krarup G., Jorgensen P., Nordentoft M. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005, 331:602.
53. Pfammatter M., Junghan U.M., Brenner H.D. Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophr. Bull. 2006, 32(Suppl. 1):S64-S80.
54. Pratt S.I., Mueser K.T., Smith T.E., Lu W. Self-efficacy and psychosocial functioning in schizophrenia: a mediational analysis. Schizophr. Res. 2005, 78:187-197.
55. Rabinowitz J., Levine S.Z., Haim R., Hafner H. The course of schizophrenia: progressive deterioration, amelioration or both?. Schizophr. Res. 2007, 91:254-258.
56. Rabinowitz J., Levine S.Z., Garibaldi G., Bugarski-Kirola D., Berardo C.G., Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr. Res. 2012, 137:147-150.
57. Raferty A.E. Bayesian model selection in social research. Soc. Methods 1995, 25:111-125.
58. Rector N.A., Beck A.T. Cognitive behavioral therapy for schizophrenia: an empirical review. J. Nerv. Ment. Dis. 2012, 200:832-839.
59. Rietschel M., Kennedy J.L., Macciardi F., Meltzer H.Y. Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies. Schizophr. Res. 1999, 37:191-196.
60. Rocca P., Montemagni C., Castagna F., Giugiario M., Scalese M., Bogetto F. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:373-379.
61. Roe D., Mashiach-Eizenberg M., Lysaker P.H. The relation between objective and subjective domains of recovery among persons with schizophrenia-related disorders. Schizophr. Res. 2011, 131:133-138.
62. Royston P., Altman D.G., Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat. Med. 2006, 25:127-141.
63. Schennach R., Meyer S., Seemuller F., Jager M., Schmauss M., Laux G., Pfeiffer H., Naber D., Schmidt L.G., Gaebel W., Klosterkotter J., Heuser I., Maier W., Lemke M.R., Ruther E., Klingberg S., Gastpar M., Musil R., Moller H.J., Riedel M. Response trajectories in "real-world" naturalistically treated schizophrenia patients. Schizophr. Res. 2012, 139:218-224.
64. Secher R.G., Hjorthoj C.R., Austin S.F., Thorup A., Jeppesen P., Mors O., Nordentoft M. Ten-year follow-up of the OPUS Specialized Early Intervention Trial for patients with a first episode of psychosis. Schizophr. Bull. 2014, 41:617-626.
65. Silverstein S.M., Bellack A.S. A scientific agenda for the concept of recovery as it applies to schizophrenia. Clin. Psychol. Rev. 2008, 28:1108-1124.
66. Strauss J., Carpenter W.T. The prediction of outcome in schizophrenia. Arch. Gen. Psychiatry 1972, 27:739-746.
67. Strauss G.P., Harrow M., Grossman L.S., Rosen C. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr. Bull. 2010, 36:788-799.
68. Strauss G.P., Sandt A.R., Catalano L.T., Allen D.N. Negative symptoms and depression predict lower psychological well-being in individuals with schizophrenia. Compr. Psychiatry Nov 2012, 53(8):1137-1144.
69. Streiner D.L. Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can. J. Psychiatry 2002, 47:262-266.
70. Van Os J., Kapur S. Schizophrenia. Lancet 2009, 374:635-645.
71. Verdoux H., Liraud F., Bergey C., Assens F., Abalan F., van O.J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophr. Res. 2001, 49:231-241.
72. White C., Stirling J., Hopkins R., Morris J., Montague L., Tantam D., Lewis S. Predictors of 10-year outcome of first-episode psychosis. Psychol. Med. 2009, 39:1447-1456.
73. World Health Organisation World Health Organization: ICD-10 Classification of Mental and Behavioural Disorders: Criteria for Research Geneva 1993.
74. Wunderink L., Sytema S., Nienhuis F.J., Wiersma D. Clinical recovery in first-episode psychosis. Schizophr. Bull. 2009, 35:362-369.
75. Wykes T., Steel C., Everitt B., Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr. Bull. 2008, 34:523-537.